PULSE BIOSCIENCES, INC. ($PLSE)
Filing Information
| Accession Number | 0001437749-26-003840 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
180,000
Total Value
$1,495,200.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 20,000 | $1.53 | $30,600.00 | 63,298 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 9, 2026 | Sale | 20,000 | $21.45 | $429,000.00 | 43,298 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 10, 2026 | Exercise/Conversion | 20,000 | $1.53 | $30,600.00 | 63,298 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 10, 2026 | Sale | 20,000 | $23.52 | $470,400.00 | 43,298 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 11, 2026 | Exercise/Conversion | 20,000 | $1.53 | $30,600.00 | 63,298 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 11, 2026 | Sale | 20,000 | $25.20 | $504,000.00 | 43,298 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (right to buy) | Derivative | Feb 9, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 405,000 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (right to buy) | Derivative | Feb 10, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 385,000 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (right to buy) | Derivative | Feb 11, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 365,000 | Direct | โ | View Details |